Ces informations sont à titre éducatif uniquement. Elles ne constituent pas un avis médical. Consultez toujours un professionnel de santé qualifié.
Description, Posologie, Effets secondaires, Contre-indications. Data from EMA, URPL, openFDA and other regulatory sources.
| Naproxen | Ibuprofen | |
|---|---|---|
| Substances actives | NAPROXEN | IBUPROFEN |
| Code ATC | G02CC02 | C01EB16 |
| Forme | TABLET, DELAYED RELEASE | TABLET, COATED |
| Posologie | 375MG | 200 mg/1 |
| Voie d'administration | ORAL | ORAL |
| Fabricant | ATNAHS PHARMA US LTD | Haleon US Holdings LLC |
Naproxen (INN: NAPROXEN, ATC G02CC02) and Ibuprofen (INN: IBUPROFEN, ATC C01EB16) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Ces informations sont à titre éducatif uniquement. Elles ne constituent pas un avis médical. Consultez toujours un professionnel de santé qualifié.